[Form 4] Tivic Health Systems, Inc. Insider Trading Activity
Jennifer Ernst, who is listed as both Chief Executive Officer and a director of Tivic Health Systems, Inc. (TIVC), reported a non-derivative acquisition of 22,541 shares of common stock with a reported price of $0, resulting in total beneficial ownership of 23,247 shares after the transaction. The filing indicates the report was made by a single reporting person and reflects an insider equity grant or transfer rather than a market purchase.
Jennifer Ernst, indicata come Amministratore Delegato e anche membro del consiglio di Tivic Health Systems, Inc. (TIVC), ha comunicato un'acquisizione non derivativa di 22.541 azioni ordinarie a un prezzo riportato di $0, con una proprietà beneficiaria totale di 23.247 azioni dopo l'operazione. La dichiarazione indica che il rapporto è stato presentato da una singola persona riportante e riflette una concessione o trasferimento di azioni per insider anziché un acquisto sul mercato.
Jennifer Ernst, a la que se la nombra tanto como directora ejecutiva como miembro de la junta de Tivic Health Systems, Inc. (TIVC), informó una adquisición no derivativa de 22.541 acciones comunes a un precio reportado de $0, resultando en una titularidad total beneficiosa de 23.247 acciones tras la operación. El informe indica que fue realizada por una única persona reportante y refleja una concesión o transferencia de acciones para insider en lugar de una compra en el mercado.
Jennifer Ernst가 Tivic Health Systems, Inc. (TIVC)의 최고경영자(CEO)이자 이사로 등재되어 있으며, 주당 0달러로 보고된 22,541주의 비파생 취득을 보고했고, 거래 후 총 지분 소유는 23,247주로 증가했습니다. 제출서는 이 보고가 단일 보고자에 의해 이루어졌으며 내부자 주식 부여 또는 양도를 반영하며 시장 매입은 아님을 나타냅니다.
Jennifer Ernst, qui est répertoriée à la fois comme directrice générale et administratrice de Tivic Health Systems, Inc. (TIVC), a déclaré une acquisition non dérivée de 22 541 actions ordinaires à un prix déclaré de $0, entraînant une détention bénéficiaire totale de 23 247 actions après la transaction. Le dépôt indique que le rapport a été effectué par une seule personne déclarant et reflète une attribution ou un transfert d’actions pour initié plutôt qu’un achat sur le marché.
Jennifer Ernst, die sowohl Geschäftsführerin als auch Vorstandsmitglied von Tivic Health Systems, Inc. (TIVC) ist, meldete einen nicht derivativen Erwerb von 22.541 Stammaktien zu einem gemeldeten Preis von $0, wodurch sich nach der Transaktion eine gesamte beherrschende Eigentümerschaft von 23.247 Aktien ergab. Die Einreichung weist darauf hin, dass der Bericht von einer einzelnen meldenden Person abgegeben wurde und eine Insider-Eigentumszuweisung oder Transaktion widerspiegelt, statt eines Marktkaufs.
شاركت Jennifer Ernst، التي تُذكر كمديرة تنفيذية ورئيسة مجلس الإدارة في Tivic Health Systems, Inc. (TIVC)، في إبلاغ عن اكتساب غير مشتق لـ 22,541 سهماً عادياً بسعر مُعلن قدره $0، مما أسفر عن ملكية مستفيدة إجمالية قدرها 23,247 سهماً بعد الصفقة. يشير الملف إلى أن التقرير مقدم من شخص واحد ويعكس منحاً أو نقل أسهم داخلي بدلاً من شراء في السوق.
Jennifer Ernst,现任 Tivic Health Systems, Inc.(TIVC)首席执行官并担任董事,被列为两职;她报告非派生性取得22,541股普通股,申报价格为$0,交易后合计实际控制权为23,247股。该备案显示该报告由单一申报人提交,反映的是内部人股权授予或转让,而非市场购买。
- Insider acquisition reported: CEO and director acquired 22,541 common shares, increasing her stake to 23,247 shares, which may align executive and shareholder interests.
- None.
Insights
TL;DR: CEO and director received an equity grant increasing her ownership modestly, aligning leadership with shareholder interests.
The reported acquisition appears to be a non-cash equity grant or similar internal issuance given the $0 price, which is a common mechanism to compensate executives or vest previously awarded awards. As both CEO and director, the reporting person’s increased ownership can signal alignment of management incentives with long-term shareholder value. The absolute size—23,247 shares beneficially owned post-transaction—is small to moderate depending on the company’s outstanding share count; the filing provides no percentage ownership, so materiality relative to total shares outstanding cannot be assessed from this document alone.
TL;DR: Non-derivative acquisition at $0 suggests internal grant; impact on float and valuation is likely immaterial without outstanding share context.
The transaction code and $0 price indicate an internal issuance such as vesting of restricted stock or a direct grant rather than an open-market purchase. For investors, the key takeaway is insider ownership modestly increased, which can be viewed positively for alignment but does not on its own imply a material change to capitalization or liquidity. The form discloses post-transaction beneficial ownership of 23,247 shares, but without total shares outstanding or percentage ownership this filing alone cannot quantify dilution or signalling magnitude.
Jennifer Ernst, indicata come Amministratore Delegato e anche membro del consiglio di Tivic Health Systems, Inc. (TIVC), ha comunicato un'acquisizione non derivativa di 22.541 azioni ordinarie a un prezzo riportato di $0, con una proprietà beneficiaria totale di 23.247 azioni dopo l'operazione. La dichiarazione indica che il rapporto è stato presentato da una singola persona riportante e riflette una concessione o trasferimento di azioni per insider anziché un acquisto sul mercato.
Jennifer Ernst, a la que se la nombra tanto como directora ejecutiva como miembro de la junta de Tivic Health Systems, Inc. (TIVC), informó una adquisición no derivativa de 22.541 acciones comunes a un precio reportado de $0, resultando en una titularidad total beneficiosa de 23.247 acciones tras la operación. El informe indica que fue realizada por una única persona reportante y refleja una concesión o transferencia de acciones para insider en lugar de una compra en el mercado.
Jennifer Ernst가 Tivic Health Systems, Inc. (TIVC)의 최고경영자(CEO)이자 이사로 등재되어 있으며, 주당 0달러로 보고된 22,541주의 비파생 취득을 보고했고, 거래 후 총 지분 소유는 23,247주로 증가했습니다. 제출서는 이 보고가 단일 보고자에 의해 이루어졌으며 내부자 주식 부여 또는 양도를 반영하며 시장 매입은 아님을 나타냅니다.
Jennifer Ernst, qui est répertoriée à la fois comme directrice générale et administratrice de Tivic Health Systems, Inc. (TIVC), a déclaré une acquisition non dérivée de 22 541 actions ordinaires à un prix déclaré de $0, entraînant une détention bénéficiaire totale de 23 247 actions après la transaction. Le dépôt indique que le rapport a été effectué par une seule personne déclarant et reflète une attribution ou un transfert d’actions pour initié plutôt qu’un achat sur le marché.
Jennifer Ernst, die sowohl Geschäftsführerin als auch Vorstandsmitglied von Tivic Health Systems, Inc. (TIVC) ist, meldete einen nicht derivativen Erwerb von 22.541 Stammaktien zu einem gemeldeten Preis von $0, wodurch sich nach der Transaktion eine gesamte beherrschende Eigentümerschaft von 23.247 Aktien ergab. Die Einreichung weist darauf hin, dass der Bericht von einer einzelnen meldenden Person abgegeben wurde und eine Insider-Eigentumszuweisung oder Transaktion widerspiegelt, statt eines Marktkaufs.